Kyowa Hakko Kirin Second Half: Japan NESP Sales Down
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin announced second half January-June results for 2013 on July 26 with sales of their renal anemia drug NESP down ¥1.8 billion from the previous term.